Quadcap Wealth Management LLC Reduces Position in Kenvue Inc. (NYSE:KVUE)

Quadcap Wealth Management LLC decreased its position in shares of Kenvue Inc. (NYSE:KVUE) by 5.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 32,729 shares of the company’s stock after selling 1,865 shares during the quarter. Quadcap Wealth Management LLC’s holdings in Kenvue were worth $699,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently modified their holdings of KVUE. Wedmont Private Capital boosted its position in shares of Kenvue by 11.5% during the 4th quarter. Wedmont Private Capital now owns 13,044 shares of the company’s stock valued at $272,000 after acquiring an additional 1,344 shares during the last quarter. Pines Wealth Management LLC acquired a new position in Kenvue in the fourth quarter valued at about $237,000. Oak Thistle LLC lifted its position in Kenvue by 13.9% in the fourth quarter. Oak Thistle LLC now owns 31,150 shares of the company’s stock valued at $665,000 after buying an additional 3,803 shares during the last quarter. Assenagon Asset Management S.A. lifted its position in Kenvue by 270.8% in the fourth quarter. Assenagon Asset Management S.A. now owns 843,901 shares of the company’s stock valued at $18,017,000 after buying an additional 616,292 shares during the last quarter. Finally, Park Avenue Securities LLC lifted its position in Kenvue by 860.2% in the fourth quarter. Park Avenue Securities LLC now owns 232,282 shares of the company’s stock valued at $4,959,000 after buying an additional 208,092 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have commented on the stock. Canaccord Genuity Group upped their target price on shares of Kenvue from $24.00 to $29.00 and gave the company a “buy” rating in a research report on Wednesday, March 5th. UBS Group increased their price target on shares of Kenvue from $24.00 to $25.00 and gave the stock a “neutral” rating in a research report on Friday, May 9th. Barclays increased their price target on shares of Kenvue from $22.00 to $23.00 and gave the stock an “equal weight” rating in a research report on Monday. Evercore ISI initiated coverage on shares of Kenvue in a research note on Monday, March 24th. They set an “in-line” rating and a $25.00 target price on the stock. Finally, Piper Sandler increased their price target on shares of Kenvue from $24.00 to $27.00 and gave the company an “overweight” rating in a research note on Monday, February 24th. Seven investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat.com, Kenvue has an average rating of “Hold” and an average price target of $25.33.

Kenvue Stock Up 2.8%

KVUE stock opened at $23.86 on Friday. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.00 and a quick ratio of 0.69. Kenvue Inc. has a 1-year low of $17.67 and a 1-year high of $25.17. The firm has a fifty day moving average price of $23.15 and a two-hundred day moving average price of $22.58. The firm has a market cap of $45.78 billion, a price-to-earnings ratio of 45.02, a PEG ratio of 2.62 and a beta of 1.02.

Kenvue (NYSE:KVUE) last released its earnings results on Thursday, May 8th. The company reported $0.24 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.01. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. The firm had revenue of $3.74 billion during the quarter, compared to analyst estimates of $3.69 billion. During the same quarter in the previous year, the firm earned $0.28 earnings per share. The firm’s revenue for the quarter was down 3.9% compared to the same quarter last year. Research analysts predict that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 28th. Stockholders of record on Wednesday, May 14th will be issued a dividend of $0.205 per share. This represents a $0.82 annualized dividend and a dividend yield of 3.44%. The ex-dividend date of this dividend is Wednesday, May 14th. Kenvue’s dividend payout ratio (DPR) is 149.09%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.